Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Surg Oncol. 2017 Apr 13;115(8):917–923. doi: 10.1002/jso.24610

Table 2.

Response results, according to treatment received.

Treatment Group Group A
RS < 11
NHT
N = 12
Group B
RS = 11–25
NHT
N = 18
Group C
RS = 11–25
NCT
N = 11
Group D
RS ≥ 26
NCT
N = 14
Overall P value
cCR 8.3% 22.2% 36.4% 28.6% 0.0422
cPR 75.0% 27.8% 36.4% 64.3%
cCR + cPR 83.3% 50.0% 72.7% 92.9% 0.0490
pCR Breast 8.3% 6.0% 0% 21.4% NS
pCR Breast + Nodes 0% 0% 0% 14.3% NS
Successful BCS 75.0% 72.2% 63.6% 57.1% NS

RS recurrence score, NHT neoadjuvant hormonal therapy, NCT neoadjuvant chemotherapy, cCR clinical complete response, cPR clinical partial response, pCR pathologic complete response, BCS breast conserving surgery, NS not significant